Elevance Health, Inc. (ELV)

NYSE: ELV · Real-Time Price · USD
315.09
+6.93 (2.25%)
At close: Sep 9, 2025, 4:00 PM
315.51
+0.42 (0.13%)
After-hours: Sep 9, 2025, 7:45 PM EDT
2.25%
Market Cap70.95B
Revenue (ttm)189.25B
Net Income (ttm)5.36B
Shares Out 225.18M
EPS (ttm)23.39
PE Ratio13.47
Forward PE10.25
Dividend$6.84 (2.17%)
Ex-Dividend DateSep 10, 2025
Volume1,926,942
Open310.55
Previous Close308.16
Day's Range309.30 - 316.88
52-Week Range273.71 - 559.95
Beta0.60
AnalystsBuy
Price Target399.00 (+26.63%)
Earnings DateOct 16, 2025

About ELV

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]

Sector Healthcare
Founded 1944
Employees 104,200
Stock Exchange NYSE
Ticker Symbol ELV
Full Company Profile

Financial Performance

In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.

Financial Statements

Analyst Summary

According to 14 analysts, the average rating for ELV stock is "Buy." The 12-month stock price target is $399.0, which is an increase of 26.63% from the latest price.

Price Target
$399.0
(26.63% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Elevance Health: Keep It Simple And Buy This Great Business At A Low Valuation

ELV stands out as an outperformer due to strong historical performance, capital returns, and a robust balance sheet. Sector tailwinds and AI-driven efficiency gains present attractive long-term opport...

1 day ago - Seeking Alpha

Elevance Health Foundation Awards $6.5 Million to Strengthen Maternal and Infant Health Across the United States

INDIANAPOLIS--(BUSINESS WIRE)--The Elevance Health Foundation has awarded 29 new grants totaling more than $6.5 million to support maternal and infant health programs across the country. The funding w...

6 days ago - Business Wire

Top 15 High-Growth Dividend Stocks For September 2025

My Top 15 high-growth dividend stocks for September 2025 are collectively 32% undervalued and offer a 1.43% yield with 21.57% five-year dividend growth. The strategy's five-year annualized return is 1...

Other symbols: ACNAPHBACBKDKSDPZGPN
8 days ago - Seeking Alpha

Elevance Health - Piggy Bank Or Headache?

Elevance and peers face earnings pressure from rising medical costs, driven by deferred care, expensive drugs, and persistent medical inflation. The segment has re-rated, and now offers good value. In...

19 days ago - Seeking Alpha

Elevance Health loses bid to challenge US Medicare star ratings

A federal judge in Texas on Tuesday rejected Elevance Health's challenge of the U.S. government's calculation for the health insurer's star ratings for some of its government-backed Medicare plans aft...

21 days ago - Reuters

Elevance Health and National Association of Community Health Centers Partnership Integrates Food as Medicine With Primary Care

INDIANAPOLIS--(BUSINESS WIRE)-- #ElevanceHealth--Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) progra...

22 days ago - Business Wire

3 SWANs On Sale

Our focus for today includes BMY, REXR, and ELV. The trio offers a safe 4.2% dividend yield, an A- credit rating average, and a 27% weighted discount to fair value. Bristol-Myers Squibb possesses a li...

Other symbols: BMYREXR
4 weeks ago - Seeking Alpha

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...

4 weeks ago - Seeking Alpha

Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence

INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company's boa...

6 weeks ago - Business Wire

Centene, Cigna, Others Drop As Molina's Results Rattle Sector

Molina Healthcare Inc. MOH missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector.

Other symbols: CICNCALHCCVSHUMMOHTHC
6 weeks ago - Benzinga

Elevance Health: CEO Buys As CareBridge Drives Strong Growth

On July 18, the CEO bought $2.4MM worth, after the sell-off following the last earnings call. Carelon Services is growing fast, supported by the December acquisition of CareBridge. The aging populatio...

6 weeks ago - Seeking Alpha

Study Finds Digital Asthma Program Significantly Improves Symptom Control in Adults

INDIANAPOLIS--(BUSINESS WIRE)-- #DigitalHealth--Study by Elevance Health, UCI, in collaboration with Apple, highlights potential of digital health tools to reduce asthma burden in U.S. populations.

7 weeks ago - Business Wire

S&P 500 Gains and Losses Today: Pepsi Stock Turns Higher; Elevance Health Tumbles

Major U.S. equities indexes pushed higher Thursday as a report revealed an increase in retail sales in June, suggesting that consumer spending remains strong despite tariff concerns.

Other symbols: PEP
7 weeks ago - Investopedia

Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More

Major U.S. equities indexes were higher at midday Thursday in the wake of better-than-expected quarterly results from several major companies. The Dow, S&P 500, and Nasdaq all advanced.

Other symbols: CSXPEP
7 weeks ago - Investopedia

Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript

Elevance Health, Inc. (NYSE:ELV) Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ET Company Participants Felicia Farr Norwood - Executive VP & President of Government Health Benefits Gail Kozi...

7 weeks ago - Seeking Alpha

Elevance Stock Falls After Earnings. What It Means for UnitedHealth, Other Insurers.

The health insurer now expects 2025 earnings of just $30 a share, citing ongoing and industry-wide impact of elevated cost trends in ACA and Medicaid.

Other symbols: UNH
7 weeks ago - Barrons

Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income

A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecas...

Other symbols: ALHCCICNCCVSMOHUNH
7 weeks ago - Seeking Alpha

Elevance cuts annual profit forecast on high medical costs

Elevance lowered its annual profit forecast on Thursday as it expects elevated medical costs in its government-backed plans to persist, sending its shares 7% lower in premarket trading.

7 weeks ago - Reuters

Elevance Health Reports Second Quarter 2025 Results

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results. "In the second quarter, Elevance Health made meaningful progress in delivering an experience that...

7 weeks ago - Business Wire

Elevance Health: Much Cheaper Than UNH, Yet No Drama

The market often misinterprets price declines as value. For Elevance Health, I see a disconnect between market cap and long-term earnings potential. Health sector valuations have dropped sharply, but ...

7 weeks ago - Seeking Alpha

Elevance Health: Should You Buy ELV Stock Ahead Of Its Upcoming Earnings?

Elevance Health (NYSE:ELV) is set to report its earnings on Thursday, July 17, 2025. For traders focused on events, analyzing past stock performance surrounding earnings announcements can yield valuab...

2 months ago - Forbes

Elevance Steps In As UnitedHealth Delays — Will It Set The Tone For Insurers?

Health insurer Elevance Health Inc. ELV is scheduled to release its second quarter 2025 financial results on July 17.

Other symbols: UNH
2 months ago - Benzinga

Eyes On Elevance Health, Not UnitedHealth, As First To Report Earnings

For years now, UnitedHealth Group has been the first of the major health insurers to report its quarterly earnings. And Wall Street analysts and investors have looked to the healthcare giant -- which ...

2 months ago - Forbes

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options

2 months ago - GlobeNewsWire

DEADLINE TOMORROW: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Contact the Firm Before July 11, 2025

PHILADELPHIA , July 10, 2025 /PRNewswire/ --  Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NY...

2 months ago - PRNewsWire